casomorphin

Member-specific names

Record a family interpretation while preserving species-specific member identities; human beta-casomorphins have been separately reported in [primary research](https://pubmed.ncbi.nlm.nih.gov/6529969/).

1. Does this record denote the casomorphin family, a specified beta-casomorphin or an unresolved commercial label? definition
2. Which naming authority establishes whether a proposed member or modified analogue belongs within this entry? boundary

Sequence and chemical form

Require sequence, termini and modifications before attaching identifiers or calculated properties.

1. What are the complete sequence, stereochemistry, terminal groups and any chemical modifications? definition
2. Which verified identifiers describe this exact peptide, and do they distinguish the free peptide from a salt or modified form? provenance

Species, variant and position

Record precursor species, casein type, variant and residue numbering as linked evidence.

1. Which casein accession, species and protein variant contain the assigned peptide sequence? provenance
2. What residue interval matches the peptide, and does numbering refer to the precursor or mature protein? definition

Conditional peptide release

Treat precursor-variant effects as condition-specific observations: [an enzymatic release study](https://pubmed.ncbi.nlm.nih.gov/10503774/) reported variant-dependent beta-casomorphin-7 release under its tested conditions.

1. Was this peptide isolated, released experimentally or synthesised, and what records establish that history? provenance
2. Which enzymes, processing conditions, pH, temperature and duration produced a measured yield of intact peptide? measurement

Sequence-specific detection

Capture orthogonal identification evidence and method-specific ambiguity.

1. Which retention-time, accurate-mass and fragment-ion observations support the assigned sequence against an authenticated standard? measurement
2. Could antibody cross-reactivity, coeluting fragments or unresolved isomers explain the reported signal? boundary

Content, purity and recovery

Record calibration, extraction recovery, matrix effects and the basis of purity claims.

1. What target concentration was measured, with which calibration standard, recovery correction and quantification limit? measurement
2. How much of the preparation is target peptide, related peptides, counterions, residual solvent or water? measurement

Usable peptide preparation

Relate counterion content, dissolution and recovery to the intended assay concentration.

1. What salt form, water content and net peptide content must be considered when preparing a molar dose? measurement
2. Under which solvent, pH and concentration conditions has complete dissolution and acceptable recovery been demonstrated? action

Stability and handling evidence

Tie storage limits and handling controls to the exact preparation and intended exposure.

1. What intact fraction remains after the proposed storage, freeze-thaw history and incubation in the relevant matrix? measurement
2. Which supplier safety information and experimentally established handling limits apply to this member and preparation? action

Assay-specific opioid response

Keep receptor binding, agonist response and antagonist-sensitive effects as distinct observations.

1. Which receptor subtype, species and assay system were tested, and was binding or functional activation measured? measurement
2. What concentration-response data and antagonist or receptor controls support attributing the response to the identified peptide? measurement

Compartment-specific evidence

Separate peptide release, survival, absorption and biological response while recording the limits of each study.

1. After which administration route was intact peptide measured, in which compartment and over what time course? measurement
2. Does the proposed interpretation require unmeasured absorption, tissue access or extrapolation from experimental doses to food consumption? boundary

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these check these first hold for the sense of casomorphin this model covers, and on what evidence? provenance

Kinds and varieties

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these kinds and varieties hold for the sense of casomorphin this model covers, and on what evidence? provenance

Identifiers and schemes

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these identifiers and schemes hold for the sense of casomorphin this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these real-world use hold for the sense of casomorphin this model covers, and on what evidence? provenance

Typical measurements

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these typical measurements hold for the sense of casomorphin this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these failure modes and hazards hold for the sense of casomorphin this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

1. Which of these neighbouring kinds and how to tell them apart hold for the sense of casomorphin this model covers, and on what evidence? provenance